Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2023.08.004Source: DataRank Database

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma is a research paper published in Journal of Thoracic Oncology (2024). On theSindex it has a DataRank of 0.373. It has been cited 11 times.

N/A

0.373DataRank · unranked

Scored on demand from live citation data

11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 1.82)OA: bronzeTopics (37)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.373

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (12)

Massimo Di Maio,Jordi Remon,Paolo Bironzo ORCID,Carlo Genova,Francesco Facchinetti ORCID

Live enrichment

PubMed:37567387 OpenAlex:https://openalex.org/W4385708681

FWCI

1.82

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jto.org/article/S1556086423007244/pdf

publisherhttp://www.jto.org/article/S1556086423007244/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1556086423007244?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1556086423007244?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtho.2023.08.004

Fields of Study

Occupational and environmental lung diseasesPleural and Pulmonary DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisHumansAntineoplastic Combined Chemotherapy ProtocolsImmune Checkpoint InhibitorsLigandsLung NeoplasmsMesotheliomaMesothelioma, MalignantPleural NeoplasmsProgrammed Cell Death 1 Receptor

MeSH Terms

Immune Checkpoint InhibitorsMesothelioma, MalignantAntineoplastic Combined Chemotherapy ProtocolsHumansLigandsLung NeoplasmsMesotheliomaPleural NeoplasmsProgrammed Cell Death 1 Receptor

Keywords

MedicineInternal medicineOncologyChemoimmunotherapyRegimenGastroenterologyResponse Evaluation Criteria in Solid TumorsMesotheliomaChemotherapySurgeryProgressive diseasePathologyCyclophosphamideImmunotherapyCombinationUnresectable

Sustainable Development Goals

SDG 0: Good health and well-being

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma

FAIR Checklist

DataRank Breakdown

Authors (12)

Impact

Open Access

Topics